MASA syndrome (OMIM 303350 
INTRODUCTION
MASA syndrome (OMIM 303350) is a rare X-linked recessive neurologic disorder also called CRASH syndrome and Gareis-Mason syndrome, spastic paraplegia 1. A more suitable name for this syndrome is L1 syndrome because the disorder has been associated with mutations in the neuronal cell adhesion molecule L1 (L1CAM) gene. The syndrome has severe symptoms in males, while females are carriers because only one X chromosome is aff ected. Only 5% of women with L1CAM mutation have clinical symptoms of the disease. The incidence is 1 per 25 000 to 60 000 males.
The acronym MASA describes four major signs: Mental retardation, Aphasia, Shuffl ing gait and Adducted thumbs. Second acronym describing this syndrome is CRASH syndrome named after corpus callosum hypoplasia, mental retardation, adducted thumbs, spastic paraplegia and hydrocephalus (1) . The following symptoms may also be diagnosed: hydrocephalus, agenesis of the corpus callosum, drinking/swallowing/feeding problems in infants and chil-dren, hypertonia, primitive tongue movements, defects of the spine, diminished growth, slightly peculiar (diff erent) facial expressions and excessive salivation, prominent forehead, and fl at feet. The severity of these abnormalities is highly variable, sometimes even within the same family (2).
The fi rst report of this syndrome appeared in 1974 by Bianchine and Lewis (3) and since then more than 200 diff erent mutations have been described.
The gene for human L1CAM is located in the Xq28 region of the X chromosome. Most L1CAM mutations reported to date are point mutations. In the normal nervous system, the synthesis and neurotrophic function of L1 is controlled by positive feedback loop which consists of L1, L 1 sheddases, gamma-secretase, L 1 extracellular domain (L1ED), L 1 cytoplasmic domain (L1CD), and transcriptional factor Pax6. The mutation in L1ED or L1CD will disrupt this feedback loop and inhibit the synthesis and neurotrophic function of L1 (6).
The neuronal cell adhesion molecule L1 (L1CAM) is a transmembrane glycoprotein belonging to the immunoglobulin superfamily and is essential in the development of the nervous system. It is mainly expressed on neurons and Schwann cells, and plays a key role in myelination, axon fasciculation, growth cone morphology, axon outgrowth and pathfi nding and neuronal migration through interactions with various extracellular ligands and intracellular second messenger systems (1) . In addition, L1 is involved in regeneration of damaged nerve tissue, and has been implicated in longterm memory formation and establishment of long-term potentiation in the hippocampus (4, 5) .
CASE REPORT
We report on fraternal twin brothers born to healthy and non-related parents that were clinically followed up for 16 years. They were born prematurely at 35 weeks of gestation from pregnancy complicated with early bleeding and gestational diabetes. The fi rst twin birth weight was 1990 g, birth length 47 cm, Apgar score 3/8/10, and second twin birth weight was 2240 g, birth length 44 cm, Apgar score 9/10/10. Immediately after birth, hypertonia of lower extremities with adducted thumbs was observed in both twins. Agenesis of the corpus callosum was detected by ultrasound in both twins.
Early psychomotor development was delayed in both twins. They attended neurodevelopmental assessment and physiotherapy. Hypertonia of lower extremities, observed at birth, during the years of follow up was replaced by spastic paraparetic form with shuffl ing gait, more prominent in second twin. Tendon refl exes were increased only on lower extremities with positive extensor plantar response. Besides clumsiness, hand function was disturbed because of adducted thumbs, as the result of hypoplasia of the extensor pollicis longus or brevis, more prominent on the left hand of both twins ( Figure 1 ). Sphincter control was adopted around six years of age. Both twins manifested primary nocturnal enuresis. Kidney ultrasounds showed mild dilatation in the channel system of both kidneys in both twins. They had problems with control of auto-aggression, sleep disorder (more pronounced in the second twin) and delayed speech development (attended speech and language therapy). Cognitive problems were observed and their mental functioning was at the level of mild to moderate mental retardation. Physical growth and development of the twins was diff erent. The height of the fi rst twin (age 16) is above 97 th percentile and of the second twin at 75 th percentile. Shuffl ing gait and adducted thumbs with distinct facial appearance of the twins was a diagnostic clue to further investigation.
In both twins, magnetic resonance imaging (MRI) of the brain showed complete agenesis of the corpus callosum, complete lack of the anterior commissure, and internal hydrocephalus without the need of surgical intervention (Fig-FIGURE 1 . Adducted thumbs, more prominent on the left hand of both twins ure 2). Electroencephalograms (EEGs) showed nonspecifi c slower dysrhythmic changes without epileptiform abnormalities.
Molecular genetic testing was done at Karl-Franzens Universität Graz. The homozygous intron 26 L1CAM gene mutation IVS26-12G→A was identifi ed in both twins. The mother is carrier of the same heterozygous mutation.
Both twins were trained by special programs (currently completing training for auxiliary painters). The boys have been very well socially adjusted, giving an impression of warm and happy young people.
DISCUSSION
In this case report, we describe dizygotic male twins with MASA syndrome caused by L1CAM mutation. L1CAM mutations can be classifi ed into three groups based on how they would aff ect the expression or structure of the protein (6) . The fi rst class of mutation includes missense mutations, nonsense mutations, frame shifts, duplications and deletions that aff ect only the cytoplasmic domain of L1 at the C-terminal end of the protein. The second class consists of missense point mutations in the extracellular domain. The third class of mutations includes nonsense or frame shift mutations that produce a premature stop codon in the extracellular domain of L1. This would result in the L1 failing to remain associated with the cell surface due to the loss of its transmembrane domain. Over 200 mutations in L1CAM have been reported; however, only a few large gene deletions have been observed (7) . The intronic mutation IVS27-12G→A detected in our patients was diagnosed by Brunner-Krainz et al. (8) 9) . It is of interest to note that single point mutation in each of the members of the same family, as presented in our cases report, results in variable clinical phenotypes, suggesting that the phenotypic expression of the L 1CAM gene is infl uenced by other genetic or environmental factors. This observation may then explain the absence of a defi nitive phenotype-genotype correlation in these X-linked syndromes (10).
Hereditary spastic paraplegias are a group of very heterogeneous disorders, both clinically and genetically, which are characterized by progressive spasticity of lower extremities. Hereditary spastic paraplegias are considered uncomplicated if only progressive spasticity is the major clinical sign, or complicated if spasticity of lower extremities is associated with other clinical features. Spastic paraplegia 1 (SPG 1) is also called MASA syndrome and according to the previously mentioned criteria MASA syndrome belongs to complicated hereditary spastic paraplegias. Shuffl ing gait in our patients is probably caused by spasticity of lower extremities, although typically shuffl e is present in patients with extrapyramidal disorders.
X-linked congenital hydrocephalus may be caused by Xlinked aqueductal stenosis (HSAS), which was not the case in our patients.
Among the major signs, hydrocephalus found in our patients is often categorized into three basic groups according to the severity: severe, moderate or absent. Severe hydrocephalus is defi ned as ventricular enlargement that requires ventriculoperitoneal shunt, cerebrospinal fl uid (CFS) drainage, hydrocephalus diagnosed in utero or described as progressive hydrocephalus having aqueductal stenosis. Patients with normal head circumference who are not described as being hydrocephalic or who showed no ventricular dilatation on imaging studies are defi ned as 'absent' concerning hydrocephalus. Our patients were in the moderate group including those that are normocephalic or mildly macrocephalic requiring no shunting procedure. According to the literature, there are about 26% of patients with MASA syndrome who have moderate hydrocephalus (6) .
A wide variety of brain malformations have been reported in association with X-linked hydrocephalus, including agen- esis of the corpus callosum or septum pellucidum, found in our patients, fusion of the thalamic fornices, colliculi and corpora quadrigemina, and absence or hypoplasia of the corticospinal tract, as assessed by histologic analysis of the pyramids in cross sections of the medulla. The latter observation provides an explanation for the spasticity present in this disease, as increased tone with hyperrefl exia are characteristic signs of corticospinal tract damage.
Also, a variety of ocular, musculoskeletal and neurologic abnormalities have been reported including nystagmus, ptosis, optic atrophy, scoliosis, torticollis, lumbar lordosis and seizures. Flexion-adduction deformities of the thumbs are frequently but not always observed. Halliday et al. (10) report on elapsed thumbs in 44% of cases and may be associated with agenesis or hypoplasia of the abductor or extensor muscles of the thumbs. In patients with MASA syndrome, mental retardation is often classifi ed into two groups: severe (IQ below 50) and modest (IQ above 50). Our twins have mild to modest mental retardation, which is found in 76% of these patients (6) .
In the literature, we found no report on a long follow up of MASA syndrome in mono-or dizygotic twins. In monitoring patients with this syndrome, it is best to involve a multidisciplinary team with expertise in pediatrics, child neurology, medical genetics, neurosurgery, rehabilitation and speech therapy. Shunting of the corticospinal tract should be performed as needed to reduce intracranial pressure. Surgery for adducted thumbs is not indicated. In some milder cases, tendon transfer and/or splint may improve thumb function.
MASA syndrome is an X-linked inherited disease. Women who are carriers have a 50% chance of transmitting the disease-causing mutation in each pregnancy. Sons who inherit the mutation will be aff ected; daughters who inherit the mutation will be carriers. Genetic testing of at risk female relatives and prenatal testing are possible if the L1CAM disease-causing mutation has been identifi ed in an aff ected family member (11) .
CONCLUSION
Our patients, dizygotic twins, show similar clinical changes typical of MASA syndrome. After identifying the specifi c genetic mutations, this family has become informative for prenatal and preimplantation genetic diagnosis, mostly because the family has a healthy girl. At present, the parents refuse genetic testing in their daughter. As testing methodology and our understanding of the genes, mutations and diseases is likely to improve in the future, consideration should be given to banking DNA of aff ected individuals. 
